Skip to main content
. 2019 Dec 20;43:e86. doi: 10.26633/RPSP.2019.86

TABLE 1. Demographic, clinical, and programmatic characteristics of smear-positive pulmonary tuberculosis (PTB) patients, Suriname, 2010 – 2015.

Characteristic

Total (n = 469)

%

Cases (n = 59)

%

Controls (n = 410)

%

P value

Sex

    Male

349

74.4

47

79.7

302

73.7

0.323a

    Female

120

25.6

12

20.3

108

26.3

 

Age (years)

    Median

  42

 

43 (37 – 54)

 

42 (31 – 51)

 

0.126a

    Age groups (years)

        15-34

158

33.7

12

20.3

146

35.6

0.036a

        35-54

240

51.2

39

66.1

201

49.0

 

        55+

  71

15.1

  8

13.6

  63

15.4

 

HIV status

    Negative

371

79.1

45

76.3

326

79.5

0.413b

    Positive

  87

18.6

11

18.6

  76

18.5

 

    Unknown

  11

  2.3

  3

  5.1

    8

2.0

 

Receiving ART

    Yes

  66

75.9

10

90.9

  56

73.7

0.241b

    No

  13

14.9

  1

  9.1

  12

15.8

 

    Unknown

    8

  9.2

  0

  0.0

    8

10.5

 

DOT

    Yes

309

65.9

41

69.5

268

65.4

0.532a

    No

160

34.1

18

30.5

142

34.6

 

Hospitalization

    Yes

417

88.9

53

89.8

364

88.8

0.898b

    No

  15

  3.2

  2

  3.4

  13

  3.2

 

    Unknown

  37

  7.9

  4

  6.8

  33

  8.1

 

Hospitalization (days)

    Median (IQR)

48 (30 – 71)

 

93 (54 – 132)

 

45 (29 – 66)

 

< 0.001c

Case type

     New

430

91.7

53

89.8

377

92.0

 

     Retreatment

  39

  8.3

  6

10.2

  33

  8.0

0.612d

Diabetes Mellitus

    Yes

  65

13.9

  5

  8.5

  60

14.6

0.200a

    No

404

86.1

54

91.5

350

85.4

 

Bacillary load

    ≤1+

196

41.8

15

25.4

181

44.1

0.015a

    2+

103

22.0

14

23.7

  89

21.7

 

    3+

170

36.2

30

50.8

140

34.1

 

Time to start TB treatment (days)

    Median (IQR)

3 (0 – 8)

 

1 (0 – 5)

 

    4

 

0.015c

Rifampicin sensitivitye

    Resistant

  27

  5.8

  4

  6.8

  23

  5.6

0.398b

    Sensitive

237

50.5

34

57.6

203

49.5

 

    Unknown

205

43.7

21

35.6

184

44.9

 

Note: HIV = Human Immunodeficiency Virus; ART = Antiretroviral Therapy; IQR = interquartile range; DOT = Directly Observed Treatment. Other risk factors included smoking, alcohol, homelessness, prison, and drug use. Hospitalization was defined as a stay of 14 days or more.

a Chi-square test.

b Likelihood ratio.

c Mann-Whitney U test.

d Values from Fisher’s exact test were used.

e Rifampicin sensitivity was only available for cases after Xpert was implemented in 2012.

Source: Prepared by the authors from the study results, based on data from the National Tuberculosis Program database, Ministry of Health, Paramaribo, Suriname, 2019.

HHS Vulnerability Disclosure